Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 19, 2000Journal of Clinical Oncology

Phase III Comparative Study of High-Dose Cisplatin Versus a Combination of Paclitaxel and Cisplatin in Patients With Advanced Non–Small-Cell Lung Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

UGU. GatzemeierOntario Institute for Cancer ResearchJPJoachim von PawelAsklepios Fachkliniken München-GautingMGMaya GottfriedMeir Medical Center

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Gatzemeier et al. (2000) studied this question.

synapsesocial.com/papers/6a0ccd4d9d761985b14a4dbchttps://doi.org/10.1200/jco.2000.18.19.3390
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Paclitaxel by 96-hour continuous infusion in combination with cisplatin: a phase I trial in patients with advanced lung cancer.1997 · 30 citations
  2. 2Phase I Trial, Including Pharmacokinetic and Pharmacodynamic Correlations, of Combination Paclitaxel and Carboplatin in Patients With Metastatic Non–Small-Cell Lung Cancer1999 · 102 citations